Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin with furosemide and mannitol for oliguria in ICU patients
IRCT2016013010741N3Phase 2Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Apr 2015
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of albumin (human), furosemide and Bronchitol in acute kidney failure (AKF), sponsored by Kerman University of Medical Sciences. Primary endpoint: Urine output. Started Apr 2015; status: completed.
02
Drugs
albumin (human)furosemideBronchitol
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on IRCT2016013010741N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016013010741N3.